Brief: Pharmagest H1 Operating Income Up At 18.7 Million Euros

Equasens SA

20/09/2019 17:20

Sept 20 (Reuters) - PHARMAGEST INTERACTIVE SA  PHAI.PA :
    * OUTLOOK FOR GROWTH AND PROFITABILITY CONFIRMED FOR H2
2019.
    * STRONG GROWTH IN ADJUSTED EPS: +19.55%, BOOSTED BY AN
EXCEPTIONAL EVENT IN MAY 2019 ( SALE OF INTECUM SHARES TO
PHARMATHEK).
    * H1 OPERATING INCOME EUR 18.7 MILLION VERSUS EUR 17.4
MILLION
YEAR AGO
    * AT 30 JUNE 2019, PHARMAGEST GROUP'S GROSS CASH POSITION
INCREASED TO EUR 104.86M, COMPARED TO EUR 95.78M AT 30 JUNE 2018
    * H1 NET PROFIT EUR 14.6 MILLION VERSUS EUR 12.2 MILLION
YEAR AGO

Source text for Eikon:  ID:nGNEccPfb1 
Further company coverage:  PHAI.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))